| Name | Role stated in the filing | Named in |
|---|---|---|
| Matthew Angel | President and Chief Executive Officer, Executive Officer, Director | 2026-10-14, 2026-06-23, 2026-04-03 |
| John Yee | Director | 2026-10-14, 2026-06-23 |
| William Richey | Director | 2026-10-14, 2026-06-23 |
| Christine Pellizzari | Director | 2026-04-03 |
| Constance Ames | Chief Financial Officer, Principal Financial and Accounting Officer, Treasurer, and Corporate Secretary, Executive Officer | 2026-10-14 |
| John Frederick | Director | 2026-10-14 |
| Justin Trojanowski | Vice President, Finance, Principal Financial Officer and Corporate Secretary, Executive Officer | 2026-06-23 |
| Michael Raab | Director | 2026-04-03 |
| Nancy Freda-Smith | Director | 2026-10-14 |
| Nicholas Maestas | Executive Officer | 2026-04-03 |
| Ronit Simantov | Director | 2026-04-03 |
| Stephen Brady | Director | 2026-04-03 |
Want the whole picture on Tempest Therapeutics, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Tempest Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Tempest Therapeutics, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Names and roles exactly as the filings list them: executive officers, directors and promoters. Nothing here is inferred, and a filing only lists the people it is required to.